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Abstract: This article seeks to explain local variations in the use of antibiotics in
the community and to assess the welfare loss due to heterogeneous attitudes
towards the risk of bacterial resistance. Quarterly data on antibiotic sales from
240 small areas in Switzerland over the course of one year are used. An
econometric ad-hoc model with spatial lags is proposed in which the demand for
antibiotics varies according to the socioeconomic characteristics of the
population, the incidence of infections, antibiotic price and local health care
supply. Using residual variations we then evaluate the welfare loss due to varying
antibiotic prescription styles. Significant differences are observed in the per
capita antibiotic consumption across local areas. Individual income, the
demographic structure of the population, physician density and the price of
drugs are all relevant determinants. We estimate that unexplained variations
may account for 12% of the total antibiotic spending in the community, thus
leading to a e6.8ml loss per year. Understanding the determinants of variations
in outpatient antibiotic consumption may help to design more effective policies
to counter the threat of bacterial resistance. Our estimate of the welfare loss due
to heterogeneous attitudes towards antibiotic treatment is comparable to the
expected cost of implementing measures to improve the dissemination of
information on bacterial resistance among patients and doctors.
1. Introduction
The use of antibiotics is far from homogeneous across geographic areas. A
European cross-country comparison shows, for example, that the per capita
outpatient antibiotic consumption in the Netherlands is three times lower
than in France (Goossens et al., 2005). Significant disparities are also observed
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across regions within a single country. In Germany, the rate of outpatient
antibiotic use per inhabitant is approximately two times greater in high-
consumption regions than in low-consumption regions (Kern et al., 2006).
This raises the question of optimal drug use, which is particularly important
in the case of antibiotics. Studies show that the increasing use of antibiotics is
associated with growing rates of bacterial resistance, which in turn reduce the
effectiveness of antibiotic treatment (Boccia et al., 2004; Coast et al., 1998;
McGowan, 2001; Levy, 1998).
The investigation of what lies behind such variation in antibiotic use across
geographic regions may help to identify sources of inefficiency in consumption.
Few studies explore socioeconomic determinants of antibiotic use in the
community.
Matuz et al. (2006) test associations between regional consumption of anti-
biotics in Hungary and possible determinants using the Spearman’s correlation
coefficient approach. Determinants include the population structure, the preva-
lence of diseases, the per capita income, free access to medicines and the density
of general practitioners and pharmacies. A significant positive correlation exists
between antibiotic use and free access to selected medicines from the public
health system, and between antibiotic use and social assistance.
Filippini et al. (2006) use an econometric approach and posit an ad-hoc
model for the demand of outpatient antibiotics in Switzerland. They find evid-
ence that antibiotic price, as well as other socioeconomic factors – such as the
proportion of foreign residents, the density of medical practices, cultural and
educational differences, and the per capita income – have a significant impact
on antibiotic consumption.
Although the above studies differ in terms of statistical approach, the
country under investigation and determinants considered, both conclude that fur-
ther analysis should be undertaken to study the determinants of antibiotic
consumption.
Although the literature is rich in studies exploring the variability ‘of antibi-
otic consumption at the hospital level1, very few studies investigate differences
in community consumption across small areas. The focus on small geographic
areas rather than on regions (counties or cantons) is desirable because smaller
areas possess greater homogeneity in terms of health conditions and other
population characteristics (Parchman, 1995). Nilson and Laurell (2005) and
Henricson et al. (1998) focus on antibiotic consumption across city districts in
Sweden and show that antibiotic use significantly varies across groups of indivi-
duals. Using a cross-sectional population survey, Muscat et al. (2006) examine
epidemiological characteristics of antibiotic use in the community in Denmark.
1 Studies include evidence from Norway (Blix and Hartug, 2005), Germany (De With et al., 2006),
Netherlands (Liem et al., 2005), Denmark (Mu¨ller-Pebody et al., 2004), France (Rogues et al., 2004) and
Switzerland (Bugnon-Reber et al., 2004).
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Generally, these studies focus on specific determinants with a descriptive
approach rather than on identifying and estimating ad-hoc models of antibiotic
demand.2
The first purpose of this article is to explore socioeconomic determinants
of small area variations in outpatient antibiotic use in Switzerland by means
of a multivariate parametric approach. We specify and estimate an ad-hoc
model for the local demand for antibiotics in outpatient care, which depends
on antibiotic price, population income, age structure, health status and some
cultural aspects of the population, as well as characteristics of the local antibi-
otic supply.
The second purpose of the article is to assess the economic impact of physi-
cians’ and patients’ heterogeneous attitudes towards the use of antibiotics,
i.e., heterogeneity in the risk perception of bacterial resistance. A common
denominator in the analysis of small area variations is that significant differ-
ences in the utilisation of health services remain unexplained after controlling
for standard determinants of demand and access. Many authors argue that het-
erogeneity in physicians’ practice styles may be an important cause of differ-
ences in medical utilisation across small areas (Wennberg, 1984; McPherson,
1990; Westert and Groenewegen, 1999; Grytten and Sorrensen, 2003). In the
use of antibiotics, after controlling for other factors, a substantial degree of
the remaining heterogeneity can be associated with physicians’ and patients’
attitudes towards the risk of bacterial resistance (Harbath et al., 2002).
Perceived levels of non-susceptible bacteria may affect physicians’ prescription
strategies and patients’ decisions (Rudholm, 2002; Laxminarayan and
Weitzman, 2002). Although average national levels of bacterial resistance are gen-
erally common knowledge, individual awareness of implications may be lacking.
To assess the impact of unobserved heterogeneity in practice style, Folland
and Stano (1989) assume that this is an omitted variable complementary to
all the explanatory variables considered in their model. Consequently, the unex-
plained variance can be interpreted as a measure of the impact of practice style
on the consumption of medical services. We argue, however, that unexplained
variations from a correctly specified ad-hoc model of the demand for antibiotics
can be interpreted as a measure of the impact of heterogeneous practices due to
uncertainty of the magnitude of bacterial resistance and different levels of risk
perception. Parente and Phelps (1990) propose a methodology to assess the wel-
fare loss due to unexplained variations in medical practice based on linear
demand curves. We build on a similar approach to calculate the welfare loss
due to heterogenous practices in the use of antibiotics in outpatient care.
2 Econometric models have been used, for instance, to investigate small area variations in the per
capita utilisation rates of medical procedures (Folland and Stano, 1989), birthweight rates (Crosse
et al., 1997), rates of ventilation tube surgery (Asche and Coyte, 2005), and hospitalisation rates for
low back problems (Joines et al., 2003).
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The article is organised as follows: Section 2 summarises the Swiss policy
context and describes variations in outpatient antibiotic use across 240 small
areas. In Section 3 we sketch a simple ad-hoc model for the local demand of
antibiotics in the community. A theoretical frame for the assessment of welfare
loss due to unexplained variations is presented in Section 3.1. Results from eco-
nometric estimations are discussed in Section 4, with Section 4.1 providing a
calculation of the welfare loss associated with unexplained variations. The con-
clusions of the article are presented in Section 5.
2. Small area variations
Switzerland is a federal state comprising 26 cantons. The country can be divided
into three macro-areas by grouping cantons linguistically (i.e., German-, French-
and Italian-speaking cantons). Health care policy, and as a consequence, the
organisation of the health care system differ from canton to canton. In general,
however, the health care system is based on a mixed (private-social) health insur-
ance system. Health insurance is mandatory for residents and the same basic
contract is offered by competing private insurance companies. The insured can
choose from a limited menu of deductibles. Physicians are reimbursed using a
straightforward fee-for-service scheme. The remuneration system is not directly
related to the prescription of drugs but patients’ perceptions of doctors may be
affected by prescription strategies.
Although average individual antibiotic consumption in Switzerland is low
compared to other European countries, it varies greatly within the country.
High levels of antibiotic use may increase bacterial resistance. Moreover, there
is the risk that resistant bacteria may enter the food chain through livestock.
The Swiss National Science Foundation (2007) argues that resistance will
very likely progress if no containment measures are undertaken. However,
Switzerland is in a ‘‘pre-pandemic’’ situation, where antibiotic resistance is
not yet perceived as an important threat by the population. Few major hospitals
in the country prepare guidelines on antibiotic use based on information on
levels of bacterial resistance collected from cantonal laboratory tests. Such
information is generally released every one or two years and, in some cases, is
delivered to general practitioners. A national surveillance database on bacterial
resistance is being developed and currently provides information for some
macro regions.
As part of a larger project investigating outpatient consumption of antibio-
tics, we collated data from the 240 contiguous market areas that make up
Switzerland. These market areas can be grouped to represent administrative
units (the cantons) and cultural/linguistic regions. Generally, a canton is made
up of between 10 and 20 market areas. Each market area exhibits high level
of internal homogeneity with respect to population and health care provider
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density. The population varies between 4,980 and 125,275 inhabitants per
area.3 Each area has at least four pharmacies and/or drugstores. Local whole-
sale quarterly data on outpatient antibiotics at the product level were obtained
from IHA-IMS Health Market Research for the year 2002. Using the number of
inhabitants4 and WHO standard doses, we calculated the defined daily doses
sold to 1,000 inhabitants per day (DID) for each of the areas.
This measure represents a good indicator of local outpatient antibiotic use.
We assume that antibiotic purchases by individuals outside their area of resid-
ence offset purchases by non-residents inside each area. We do not take into
account the difference, if any, between the quantity of antibiotics sold and the
quantity actually consumed, assuming patient’s non-compliance to be a negli-
gible factor. Finally, the potential mismatch between wholesale records and pre-
scribing data due to seasonal fluctuations of retailers’ stocks is assumed to have
only a limited temporary effect and is likewise ignored.
As illustrated in Fig. 1, there is a great heterogeneity in antibiotic use even
across small areas within cantons5. The mean DID (across the small areas) is
11.71 and varies between a minimum of 4.65 and a maximum of 16.77 at the
cantonal level. Note, however, that within-canton variation is much greater
because the minimum DID in a small area is 3.18 (AG), whereas the maximum
DID value is 141.27 (ZH).
Figure 1. Within-canton variations in per capita antibiotic use (2002)
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3 This is smaller than the population generally observed in similar studies, for instance Folland and
Stano (1989) identify 15 areas in the State of Michigan to investigate intermarket variations in the per
capita utilisation rate of surgical procedures. More recently, Dubois et al. (2002) considered areas with
population ranging between 16,052 and 166,316 individuals.
4 Information for the year 2002 were derived from projections using the population census of 2000.
5 The box and whiskers plot illustrates antibiotic use within cantons. We aggregate five small can-
tons into two bigger regions. Consequently, the number of cantons is reduced to 23. The horizontal
line inside the shaded box represents the mean cantonal consumption of antibiotics. The width of the
shaded box includes consumption in the second quartile, i.e., 50% of the small areas in the canton.
Finally, the length of the two whiskers illustrates the third quartile of observations, i.e., 75% of the
small areas.
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3. The model
There may be several reasons for variations in the use of antibiotics across small
areas. All other things being equal, we hypothesise that four main factors affect
inter-area variability: the incidence of community-acquired infections, the local
supply of community care, population characteristics (age structure and
income, cultural aspects) and the price of antibiotics. In addition, antibiotic
use could be influenced by the level of bacterial resistance and antibiotic con-
sumption in adjacent areas. The magnitude of bacterial resistance country-
wide is known to doctors and patients, but such figures are not broken down
for smaller areas. We operate on the assumption that bacterial resistance does
not vary across local areas but that local doctors and patients may have differ-
ent attitudes towards the use of antibiotics. This means that the perceptions of
the implications of bacterial resistance differ across the areas.
We specify an ad-hoc demand model to explain variations in the per capita
use of outpatient antibiotics across the small areas. The dependant variable is
the defined daily doses per 1,000 inhabitants described earlier. All other things
being equal, we assume that for the area i:
DIDi¼ f ðYi;POPji; INFki;DPHYi;DPHAi;Pi;DLATi;DBORi;DTtÞ; ð1Þ
where Yi is the average income of residents in the area i, POPji is the percentage
of the population in the j age range; INFki is a proxy for the health status of the
population represented by the incidence of k main bacterial infections at the
cantonal level; DPHYi and DPHAi are respectively the density of physicians
and pharmacies in the area; and Pi is the price of a defined daily dose in period
t 1. Lagged values for prices are used to reduce the risk of endogeneity
between quantities and prices.
DBORi is a dummy that captures any borderland effects with neighbouring
countries and DLATi is a dummy that considers whether an area is mainly char-
acterised by Latin (French- and Italian-speaking) or German culture. Finally,
DTt are time dummies that identify the four quarters of the year, with DT4
(October, November, December) the baseline quarter. Defined daily doses of
outpatient antibiotics per capita are expected to be higher during winter and
lower in the spring and summer periods, as pointed out by Goossens et al.
(2005).
Because patients’ preferences for antibiotics in one area may reflect indivi-
duals’ attitudes towards antibiotics in adjacent areas, we need to consider the
potential impact of spatial dependency. The issue is further discussed with the
model specification at the end of this section.
Our dataset includes quarterly information for the year 2002 and for the 240
regions on covariates defined in equation (1). Summary statistics are reported in
Table 1.
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Among the idiosyncratic characteristics of the population, we include the
demographic structure, socioeconomic aspects and cultural attitudes. We con-
sider five age groups: 0–14, 15–25, 26–59, 60–74 and over 74. For example,
if the antibiotic therapy represents a time-saving choice for individuals in the
work force, one might expect that middle-aged individuals are more likely to
use them, ceteris paribus. This hypothesis is in accordance with the findings
of Mousque`s et al. (2003), who studied general practitioners’ antibiotic pre-
scriptions for rhynopharingitis infections. On the other hand, the elderly may
be less exposed to community-acquired infections, even though more suscept-
ible, or be more concerned with the implications of bacterial resistance and
hence use less antibiotics. We hypothesise that children are more likely to be
prescribed an antibiotic than adults ceteris paribus. It can be argued that doc-
tors and patients may be concerned with the potential harmful effect of delaying
antibiotic treatment for the very young.6 Resi et al. (2003) find that the percent-
age of children receiving antibiotics decreases as they grow up. Whereas 70% of
children between 1 and 2 years of age received at least one prescription during
2002, this was the case for only 36% of young people 11 years old or older.
Table 1. Variables notation and summary statistics
Variable Description Mean Std dev.
DID Defined daily doses per 1,000 inhabitants 11.714 13.061
Y Income per capita defined in CHF 23465 6849.4
POP1 Proportion of 0–14 in total population 0.1658 0.0243
POP2 Proportion of 15–25 in total population 0.1247 0.0173
POP3 Proportion of 26–59 in total population 0.4956 0.0314
POP4 Proportion of 60–74 in total population 0.1363 0.0213
POP5 Proportion of over 74 in total population 0.0776 0.0190
INF Incidence of common gastrointestinal infections
(salmonella and campylobacter) in 100,000 inhabitants
114.69 22.580
INF2 Incidence of common respiratory infections
(streptococcus) in 100,000 inhabitants
64.977 41.060
DPHY Density of physicians for 100,000 inhabitants 565.21 1052.5
DPHA Density of pharmacies for 100,000 inhabitants 35.098 39.112
P Price of a defined daily dose 3.7112 0.3113
DBOR Whether or not the area borders another
country/other countries
– –
DLAT Whether an area has a Latin (French and Italian) or
a German culture
– –
6 Swiss paediatricians cite the danger of potentially fatal complications of bacterial infections in
children (whose resistance is lower than adults’), such as rheumatic fever from streptococcus infections.
The incidence of rheumatic fever among children has declined a great deal historically, but no one has
been able to discern whether this is due to antibiotic use or just generally improved hygienic conditions.
Lacking data, doctors are inclined to prescribe antibiotics when children test positive for bacterial
infections.
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As for socioeconomic factors, Henricson et al. (1998) show that the level of
income is positively correlated with the use of antibiotics. Attitudes towards
antibiotics may also be affected by cultural/linguistic aspects. Lecomte and Paris
(1994) suggest that sociocultural factors may explain differences in consump-
tion patterns between European countries. Elsevier et al. (2007) show that
southern European countries consume higher doses of outpatient antibiotics
per capita. Because Swiss regions are characterised by German-, French- and
Italian-speaking communities, we want to investigate whether these linguistic
communities’ attitudes towards antibiotics mirror those of German, French
and Italian speaking countries in Europe. Filippini et al. (2006) show that
French- and Italian-speaking cantons consume more antibiotics compared to
German-speaking cantons. This claim can now be inspected using data from
small areas. Forty-four percent of our small areas are characterised by Latin
(French and Italian) culture. Around 12.5% of the areas have a border with a
foreign country. The density of foreigners or working commuters from other
countries may also affect the per capita use of antibiotics.
The characteristics of the local supply of community health care can be cap-
tured by the availability of practices and pharmacies in the area. In our dataset
the number of physicians per 100,000 inhabitants ranges from 43 to (in one
special case) 10,730. The coefficient of variation is around 3 and suggests that
there are large variations across the areas. Besides physicians’ density we
observe large differences in the density of pharmacies across the small areas.
The number of pharmacies per 100,000 inhabitants varies between 4.8 and
333. In the context of primary care, Grytten and Sorensen (2003) find that
physician-specific effects in Norway explain between 47% and 66% of differ-
ences in expenditure. Folland and Stano (1990) suggest that the primary care
physician to population ratio reflects the supply of medical services and consti-
tutes a potential explanation for small area variations in the use of health care
services. Similarly, we hypothesise that the density of physicians may affect the
probability of antibiotic prescriptions under imperfect information on the
impact of bacterial resistance, ceteris paribus.
Differences in the incidence of infections among geographic areas are also
likely to impact the per capita use of antibiotics. Note, however, that remark-
able seasonal fluctuations suggest that the incidence of the most relevant
community-acquired infections, such as influenza and pneumonia, also vary
widely during the year. Data on bacterial infections are based on information
on the incidence of common gastrointestinal and respiratory diseases. As indica-
tors we use the incidence of campylobacter and salmonella infections, the lead-
ing causes of gastrointestinal infections, and the incidence of Streptococcus
pneumonie infections which represent the most common airborne bacterial
infections among the population. In most cases patients recover without any
medical treatment. However, patients, especially children and elderly patients,
may be prescribed antibiotics when symptoms are particularly severe. Data on
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gastrointestinal infections are generally more reliable than those for airborne
bacterial infections. However, the latter are also included in the model lest their
omission impact residual variations.7 Our information comes from yearly pub-
lications of the Swiss Federal Statistical Office at the cantonal level.
Although individuals bear only a small fraction of the cost of antibiotics,
differences in health insurance co-payments and deductibles may influence the
price elasticity of the demand. Moreover, competition and wholesalers’ mar-
keting strategies may vary across the areas, thus leading to significant price
differences. Consequently, the price of antibiotics may account for variance in
consumption across small areas. The price of a defined daily dose is calculated
quarterly and varies between CHF 2.81 and CHF 4.80.
The information on prescription and consumption practices related to doc-
tors’ and patients’ risk aversion in the use of antibiotics has been omitted in
our model and local rates of antimicrobial resistance cannot be observed. The
interpretation of unexplained variations from equation (1) will be addressed
in detail in Section 3.1.
To investigate the responsiveness of local per capita antibiotic sales to
changes in the explanatory variables, we use a linear specification8 of the model
defined by equation (1). Coefficients represent changes in the value of the
dependent variable corresponding to variations in the value of each explanatory
variable, ceteris paribus. Unexplained variations are assumed to be indepen-
dently and identically normally distributed.
From the econometric point of view, we should consider that our dataset is
characterised by a relatively small number of time periods (t¼ 3), a relatively
large number of cross-sectional units (N¼ 240) and zero within-variation for
most of the explanatory variables. The only two variables that change over
time (three quarters) are the outpatient per capita consumption and the price
of a daily dose. Hence, the typical model for panel data, e.g., the least squares
dummy variable model and the error components model, are not appropriate.9
7 Because residual variations are used in Section 3.1 to calculate the welfare loss from attitudes
towards bacterial resistance, our model assumes that the variability in the use of antibiotics due to the
spread of diseases is accurately captured by the two indicators. Of course, we are aware that residual var-
iations may be influenced by the incidence of infectious diseases besides those modeled in the article.
However, the inclusion of foodborne, waterborne and airborne infections may substantially reduce this
possibility.
8 This simplifies the following analysis of the welfare loss due to heterogeneous attitudes towards the
risk of bacterial resistance, and implies that the marginal individual benefit from consumption of a
defined daily dose of antibiotics varies at constant rates. Although non-linear demands may be more real-
istic, results from our linear regression show that the adjusted R2 is quite high and alternative specifica-
tions (log-log) add little.
9 The reliability of these estimators depends on the extent of within-regional as well as between-
regional variations of the dependent and the independent variables. As Cameron and Trivedi (2005)
point out, the fixed-effects approach has an important weakness in that the coefficients of the explana-
tory variables are ‘‘very imprecise’’ if the variable’s variation over time is dominated by variation across
regions (between variation).
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An econometric problem that could arise when estimating the demand model
(1) is spatial correlation due to spatial dependency in antibiotics consumption.
For this reason, we use a spatial two-stage least-square (S-2SLS) estimation
procedure.10
Because we use time lags for the price, the first quarter (January, February
and March) is excluded from the regressions. The estimation is performed using
the econometric software STATA.
3.1. Unexplained variations
We now focus on the analysis of unexplained variations in the use of antibiotics
in ambulatory care after controlling for the demand and supply-side determi-
nants considered above. The literature suggests that unexplained variations in
medical practice may be associated with unobserved heterogeneity in physi-
cians’ practice styles but omitted factors may also be related to patients’ prefer-
ences. As posited by Stano (1993) patients’ preferences may interfere with the
impact of practice style in the residual variations.
In the case of antibiotics, unexplained variations are plausibly related to
differences in doctors’ and patients’ attitudes towards the risk of antibiotic
treatment, i.e., the impact of bacterial resistance. National average levels of
bacterial resistance are common knowledge but doctors and patients may be
assumed to differ in their level of risk aversion. Doctors have two options: pres-
cribe antibiotics at the first consultation despite uncertainty about the nature of
the infection, or delay antibiotic treatment until the type of infection is deter-
mined. The former strategy may appease the patient but increases the risk of
developing bacterial resistance. The latter strategy reduces the risk of bacterial
resistance but may increase recovery time, and hence the opportunity cost for
the patient.
We assess the welfare loss from unobserved heterogeneity in the use of out-
patient antibiotics building on a frame developed by Parente and Phelps
(1990). The method relies on the determination of the loss of consumer surplus
due to a shift in the linear demand curve. Figure 2 illustrates the market for
antibiotic treatment. We presume that local variations arise from parallel shifts
in the antibiotic demand curve between observed ‘‘uninformed’’ locations (V0
and V1) and a ‘‘fully informed’’ demand curve (V*) to which patients would
move if they possessed all relevant information about the value of antibiotics.
The ‘‘fully informed’’ demand curve would be the aggregate of all value curves
for individuals and captures the social marginal benefit of antibiotic utilisation.
10 We estimate a spatial-lag model (using Spatial Two-Stage Least-Square estimation) which assumes
that the spatially weighted average of consumption in adjacent regions (DIDi) affects the consumption
in each region in addition to the standard explanatory variables. Spatial lags of exogenous variables and
cantonal dummies are used as a set of instruments to estimate the mean antibiotic consumption in regions
which are contiguous with region i. For more detailed explanation see Anselin (2001) and Kelejian and
Prucha (1998).
64 M A S S I M O F I L I P P I N I E T A L .
at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S174413310800460X
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 19:01:14, subject to the Cambridge Core terms of use, available
This means that the implications of bacterial resistance are also taken into
account. We assume that bacterial resistance does not vary locally and the
aggregate level of antibiotic resistance is common knowledge among prescri-
bers. This assumption is plausible given the low average levels of antibiotic con-
sumption in Switzerland. Marginal benefits of antibiotic treatment are
decreasing at constant rates. Many analyses of medical interventions rest
upon this assumption. In the case of antibiotics, increasing daily doses may
reduce antibiotic effectiveness because of the selection of resistant bacteria.
The level of antibiotic use that maximises consumer’s well-being (DID*) in
each small area is the point where the marginal value just equals the marginal
cost of antibiotic treatment (p*). We calculate the ‘‘optimal’’ amount of antibiotics
as the average per capita rate of antibiotic use across all the small areas. Antibiotic
use in each area measures consumption by the representative individual. This is
ensured by the homogeneity of individuals’ characteristics within each area.
The marginal cost of a defined daily dose is constant and is given by the aver-
age antibiotic price across the areas.11 This requires that the market price repre-
sents the full cost of antibiotic use and that patients do not incur additional
incremental costs. Patients generally pay drug costs until their deductible has
been reached. The cost of a consultation represents a fixed cost that presumably
does not increase with the number of individual doses. It also requires that the
market for antibiotics be competitive. Generally, new, branded antibiotics are
Figure 2. The loss of consumer surplus due to variations in the use of antibiotics (shaded
areas). Heterogeneous attitudes towards bacterial resistance lead to shifts in the ‘‘fully
informed’’ demand cure (V*) to ‘‘uninformed’’ locations (V0 and V1)
P*
V1(DID)
V0(DID)
V*(DID)
DID*DID1 DID0
Incremental value
Price
DID
11 The price of a daily dose may fluctuate across small areas for at least two reasons. First, antibiotic
classes may be used in different proportions across the areas. Second, discount strategies may be applied
by the wholesalers to the retailers.
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sold under patent protection. Their market price may include research and
development costs of new drugs because bacterial resistance undermines the
effectiveness of previous generations of antibiotics. Note, however, that many
types of antibiotics are traded in the generic drug market and that regulators
are increasingly adopting mechanisms of reference pricing, which imply com-
parison with prices set in other countries.
Given this frame, we can quite naturally estimate the welfare loss from un-
der- and over-consumption due to cross-area differences in utilisation. The pro-
cedure uses the residuals from equation (1) in order to account for systematic
differences in consumption across areas due to factors such as age, income,
price and infections.12 Our explanatory factors are unaffected by the demand
for antibiotics in outpatient care, and are thus truly exogenous. The incidence
of mild respiratory and gastrointestinal epidemic infections (for instance, influ-
enza) is presumably independent of antibiotic use in outpatient care. Physicians’
and pharmacies’ density are also independent of antibiotic consumption in the
community because licences are usually regulated by the cantons. The slope of
the demand curve is represented by the estimated coefficient of price from the
linear regression of equation (1).
As demands are linear, the total daily loss for 1,000 inhabitants due to the
misuse of antibiotics (shaded areas in Figure 2) adds up all of the values of inap-
propriate consumption over the N areas. Hence, the total loss is the sum of all
the welfare loss triangles:
W ¼ 1
2
XN
i¼1 DDIDiDVi ð2Þ
where DDIDi and DVi represent deviations from the ‘‘optimal’’ level DID* and
V*. The value of residual variations in the use of antibiotics is then obtained by
summing the value of deviations from the estimated (efficient) level of antibiotic
use across the areas.
To approximate DVi we assume that V
0 is the slope of the demand curve and
we have DV¼V0 (DIDiDID*). Then we can rewrite equation (2) as
WDID ¼ 1
2
V 0
XN
i¼1 DIDi DID
ð Þ2 ¼ N
2
V 0s2DID; ð3Þ
where s2DID is the variance of the defined daily doses per capita across the areas.
The above definition of welfare loss matches data available in the aggregate after
some algebraic adjustments. We define « as the percentage of change in DID
for a one percent change in V. Hence, «¼ (dDID/DID)/(dV/V)¼V/(V0 DID).
12 Of course, we are aware that the estimated welfare loss associated with variations may be suscept-
ible to error if some of our assumptions do not hold. For further discussion see the debate between
Dranove (1994) and Phelps (1995) on this issue.
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Similarly, we convert the variance measure into an expression using the coefficient
of variation (CV). Finally, the ‘‘correct’’ use of antibiotics provides value just equal
to the marginal cost of a daily dose. We divide the variance by the square of the
average use to obtain CV2¼s2/DID*2. Thus, we can write equation (3) as
WDID ¼ 1
2"
CV2VDIDN: ð4Þ
We can re-scale (4) to calculate the total welfare loss for one year for the whole
Swiss population. We multiply WDID by (365POP), where POP is the Swiss
population divided by 1,000. We then obtain
WDDDs¼ 1
2"
CV2VDDDs; ð5Þ
where DDDs is the total number of doses used for one year by the entire Swiss
population. Consequently, V*DDDs represents the total Swiss spending on out-
patient antibiotic use.
4. Empirical results
Four groups of determinants of small area variations in outpatient antibiotic use
are included in the model defined by equation (1): (i) the incidence of infections;
(ii) the demographic, socioeconomic and cultural aspects of the population;
(iii) the supply of health care in the community; and (iv) antibiotic price. A pre-
liminary investigation shows that correlation coefficients between the depend-
ent variable and the explanatory factors are all significant on the basis of a
two-tailed test.
The estimation results obtained using the S-2SLS estimation procedure are
reported in Table 2. The estimated spatial autoregressive parameter associated
with the lag term DIDi is significant and negative. This indicates that the
S-2SLS model should be preferred to the Ordinary Least Squares (OLS)
model.13
Perhaps the first point to note is that the adjusted R2 suggests that selected
variables explain approximately 87% of small area variations in the use of
antibiotics in the community. This figure is very close to the one estimated in
13 Our result suggests the evidence of positive consumption externalities across the areas. Higher
antibiotic consumption in one area is significantly associated with lower antibiotic consumption in adja-
cent areas. A plausible explanation for this result is related to the double role of antibiotics. Antibiotics
are used to cure bacterial infections and to prevent the spread of infections and bacterial resistance to
other individuals. Consequently, the use of antibiotics in one area minimises the spread of infections in
neighbouring areas. This implies that a smaller amount of antibiotics is required to obtain the same level
of health benefits. Although patients’ imperfect information may suggest that this effect is not interna-
lised by the individual, antibiotic prescribers such as general practitioners are quite likely aware of this
effect.
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Filippini et al. (2006) with a log-log model specification and cantonal data (the
adjusted R2 is between 0.887 and 0.9).
The positive relationship between DID and income is significant at less than
0.1% and suggests that richer areas spend more on outpatient antibiotics per
capita than lower income areas. The result is in accordance with findings by
Nilson and Laurell (2005), who analysed the impact of socioeconomic factors
on antibiotic prescriptions in a Swedish city. Similarly, Henricson et al.
(1998) found that antibiotic consumption is higher in higher income districts.
However, our coefficient is relatively low and may indicate that antibiotics in
outpatient care are not as strong normal goods as Baye et al. (1997) suggest
for anti-infectives (elasticity around 1.3). Indeed, our calculated income elasti-
city is 0.37.14 In a previous analysis at the regional level we found negative
income elasticity around 0.5. Our finding seems to indicate that the Swiss
higher-income population is likely to substitute alternative treatment for anti-
biotics than the comparable American population considered in Baye et al.’s
study. This may be related to the awareness of the perverse effects of bacterial
resistance. This explanation fits with the relatively low per capita antibiotic
Table 2. Determinants of outpatient antibiotic use (2002 quarterly) across small areas from spatial two-
stage least square regression
Equation Obs. Parms RMSE Adjusted R2 F-Stat p-value
DIDi 720 15 4.6 0.87 319.64 0.000
DIDi 720 46 1.84 0.92 176.06 0.000
Covariates Coefficients Std. Err. p-value
Constant 13.73944 5.251623 0.009
Y 0.000187 0.000033 0.000
POP1 50.74812 16.57302 0.002
POP2 49.57082 20.33704 0.015
POP4 49.55307 13.94125 0.000
POP5 44.15414 12.45914 0.000
DBOR 0.165596 0.587630 0.778
DLAT 3.068978 0.511633 0.000
INF 0.018375 0.010098 0.069
INF2 0.012642 0.006187 0.041
DPHY 0.000555 0.000210 0.008
DPHA 0.297510 0.006029 0.000
Pt1 2.086065 0.637740 0.001
DIDi 0.189367 0.038492 0.000
DT2 2.424057 0.439328 0.000
DT3 2.668702 0.427910 0.000
14 We calculate elasticities at mean values of antibiotic use and covariates using summary statistics in
Table 1 and the regression coefficients of our estimation.
68 M A S S I M O F I L I P P I N I E T A L .
at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S174413310800460X
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 19:01:14, subject to the Cambridge Core terms of use, available
consumption in Switzerland compared to other countries. Note also that Baye
et al.’s study is based upon 1984–1990 data. The increasing concern over the
effects of bacterial resistance throughout the 1990s may have reduced
the income elasticity of outpatient antibiotic expenditure over time, thus leading
to our lower elasticity value. Finally, our data may not capture the effect of
retailing strategies associated with income because such strategies are not aimed
at the final consumer. We use total outpatient antibiotic wholesales to pharma-
cies, drugstores and medical practices, whereas Baye et al. use retailing prescrip-
tion data collected through surveys of a sample of pharmacies.
Our analysis of the impact of demographic variables on outpatient antibiotic
consumption is plausible. The impact of the proportion of children between 0
and 14 years of age on the total population (POP1) reflects some health consi-
derations. Because children are largely exposed to infections in childcare facilities
and school, imperfect information on the type of infection may lead physicians
and parents to provide them with antibiotics in order to minimise the risk of
complications and possibly contagion. In terms of elasticity, a 1% increase in
the proportion of children increases the use of antibiotics per capita by 0.72%.
Also of interest is the negative coefficient of the proportion of individuals
over 74 years of age (POP5) compared to the baseline category. The calculated
elasticity is 0.29. A similar impact is observed for the proportion of indivi-
duals between 60 and 74 (POP4) with elasticity around 0.58. This suggests
that elderly people may be less exposed to the risk of infections in the commun-
ity or that they are more concerned with the implications of bacterial resistance.
However, it could also imply that elderly people are more likely to obtain
hospital referrals for such infections, ceteris paribus, and hence to receive
antibiotic treatment within the hospital. Our result is in accordance with find-
ings by Mousque`s et al. (2003), who investigated a panel of general practi-
tioners prescribing antibiotics for rhynopharingeal infections.
We argue that the consumption of anti-infectives in the community differs
from the use of other health care services, and consequently does not follow
the same trajectory over an individual’s lifetime. Antibiotic treatment is likely
delayed in the young and the elderly until confirmation of bacterial infection
in order to avoid resistance implications. On the other hand, the antibiotic ther-
apy can be conceived as a time-saving choice and hence more likely to be
adopted by individuals in the work force. The literature on the determinants
of health care expenditure generally suggests that the increasing prevalence of
chronic health problems associated with aging may cause an increase in the
utilisation of health care services. For instance, Di Matteo and Di Matteo
(1998) and Di Matteo and Grootendorst (2002) investigate the determinants
of the real per capital provincial government health expenditure in Canada
using a log-log functional form. They calculate a slightly positive elasticity of
the proportion of the population aged over 64 years. However, the result is
not confirmed by a more recent study (Di Matteo, 2005).
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Another point of interest is that areas at the border between Switzerland
and other countries may share similar attitudes towards antibiotics for at least
two reasons. First, the foreign workers may influence the perception of the
need for antibiotic treatment in the area. Second, physicians’ attitudes regarding
the prescription of antibiotics may be influenced by practice styles and the pub-
lic perception of the need for antibiotics in neighbouring countries. We test this
hypothesis in the light of differences observed in antibiotic consumption across
Europe (Goossens et al., 2005). Previous findings by Filippini et al. (2006) show
positive and significant coefficients for these covariates. The percentage of
foreigners in the total population increases the cantonal per capita outpatient
antibiotic expenditure.
Although the ‘‘Latin’’ dummy suggests that antibiotic expenditure is higher
in French- and Italian-speaking cantons compared to German-speaking cantons,
these results are not confirmed by the current findings. The coefficient of
DBOR is not significant. Moreover, the coefficient of DLAT is negative. Areas
characterised by French and Italian culture are associated with lower antibiotic
use compared to areas with German culture. Note, however, that the univariate
correlation with the dependent variable is positive. Dropping DLAT from
the multivariate model does not affect the other results significantly. The reason
for such an effect is plausibly the interaction with local supply factors, i.e., the
density of pharmacies. Because French- and Italian-speaking areas generally
exhibit a higher density of pharmacies compared to German-speaking areas,
it is difficult to pinpoint the effect of different cultural attitudes on the use of
antibiotics.
The coefficients of the incidence of infections exhibit the expected positive
sign. Both common gastrointestinal infections and common respiratory infec-
tions have an impact at less than 10% significance level. This result suggests
that epidemiological differences are relevant in explaining variations in the
use of antibiotics in the community. However, outpatient antibiotic expenditure
does not seem to be very elastic with respect to epidemiological factors. Our cal-
culated elasticities vary between 0.07 for respiratory infections and 0.18 for
gastrointestinal infections. Similarly, Filippini et al. (2006) find positive and sig-
nificant coefficients and their elasticity is very low. Note that the lack of quar-
terly data on the incidence of bacterial infections in our dataset may dilute the
seasonal impact of infections on antibiotic consumption. Some seasonal effects
are captured by time dummies.
Local supply factors are positively associated with the per capita antibiotic
use. The level of significance is higher for the density of pharmacies than for
the density of physicians. There is a slight correlation between the two covari-
ates. We find that a 1% increase in the density of physicians raises antibiotic
consumption by 0.03%, whereas the elasticity of antibiotic consumption to
the density of pharmacies is 0.89.
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The density of physicians is often used to measure the extent of the supplier-
induced demand (SID) phenomenon in the empirical literature.15 This variable
is likely to be associated with higher per capita use of antibiotics, if physicians
can compensate for the increased pressure on their income due to the reduced
number of patients per doctor by increasing the amount of services provided
to each individual (Carlsen and Grytten, 1998). The literature generally suggests
that in systems where physicians are paid under a fee-for-service scheme, akin to
the Swiss one, overconsumption of drugs is more likely. Given that daily doses
are standardised, our result may suggest that variations in physicians’ practices
might either take the form of differences in the number of antibiotic treatments
per person or of differences in daily dosage schedules.
On the other hand, a recent study by Davis et al. (2000) analyses medical
practice variations in New Zealand and does not find any evidence of SID. Simi-
larly, Di Matteo and Grootendorst (2002) estimate that the per capita number
of prescribing physicians is a negative, although not a significant, determinant
of Canadian drug expenditure. More closely related to antibiotic consumption,
Garcia-Rey et al. (2004) find a negative correlation between the number of phy-
sicians per capita and differences in antibiotic use across Spanish provinces.
Supplier-induced demand may be unlikely in the Swiss context because physi-
cians generally do not receive remuneration for prescriptions. More plausibly,
physician density may increase the use of drugs by reducing patients’ access
costs to physicians services. Indeed, the strong impact of the density of pharma-
cies may indicate that patients are more likely to purchase antibiotics if a
pharmacy is located nearby their residence, ceteris paribus.
As expected, price has a negative and significant impact on antibiotic use in
the area. Swiss consumers bear only a small fraction of the total cost of drugs
directly because of compulsory health insurance. However, antibiotic sales my
be affected by price changes because of standardised deductibles and copay-
ments. On the other hand, the demand for antibiotics may be more inelastic
compared to other types of drugs because antibiotics are generally purchased
under doctor’s prescription. Our estimate of price elasticity (0.66) is slightly
lower in absolute value than that of Baye et al. (1997), who calculate both
compensated (0.785) and uncompensated (0.916) own-price effects. Our
findings support their argument that anti-infectives have the most significant
own-price elasticities among all major pharmaceutical classes. Focusing on the
demand for one antibiotic class, the cephalosporins, Ellison et al. (1997) calcu-
late own-price elasticities for different brand/generic names irrespective of drug
expenditure using US wholesale data from 1985 to 1991. Their estimates range
from 0.38 to 4.34. Our results could also be compared to the ones found in
Rudholm (2003), who derives own-price elasticities for three Swedish pharma-
ceuticals submarkets for each year between 1989–1996. However, it is the
15 See McGuire (2000) for a review.
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prescription drug market for b-receptor blocking agents that may be most
similar to our outpatient antibiotic market, although not identical. Mean
own-price elasticities calculated by Rudholm are also negative and significant
at 5% level, ranging between 0.12 and 3.43. A shorter range (from 1.62
to 2.13) is covered by elasticities estimated by Rizzo (1999) using wholesales
data from the US antihypertensive drug market.
Finally, we find remarkable seasonal effects on antibiotic consumption.
The baseline season is represented by the fourth quarter, i.e., the autumn
dummy (October, November, December). Per capita outpatient antibiotic
use is expected to be lower in the second and the third quarters of the year,
as pointed out by Goossens et al. (2005). Our estimated coefficients for the
second and the third quarters (DT2 and DT3) are both negative and highly
significant. This connotes lower per capita outpatient antibiotic use during
spring and summer periods, possibly because the risk of bacterial infections is
then lower.
4.1. Welfare loss assessment
Using equation (5) above, we can calculate the total welfare loss from antibiotic
use for the Swiss population for one year. As stated in Section 3.1 we use the
residuals from the estimation of the demand curve defined by equation (1).
With this procedure, we control for differences in the socioeconomic character-
istics of the areas, the incidence of infections and access to physicians and phar-
macies.
The adjusted coefficient of determination derived in Section 4 denotes
that heterogeneity in physicians’ and patients’ attitudes towards antibiotic
use accounts for 13% (1R2) of total variations. The unexplained residual
variance s2DID is computed as the raw variance times (1R2), the proportion
of variance left unexplained by the regression. We use this computation to
calculate the coefficient of variation CV. Similarly, we compute the elasticity
« at average ‘‘correct’’ levels of antibiotic use (DID*) and marginal cost (V*)
using the estimated price coefficient from our regression to approximate the
slope of the demand curve V0. Finally, our dataset includes detailed information
on the antibiotic sales for each small area quarterly. We use this information to
calculate the total spending on antibiotics for the entire Swiss population in
2002.
We summarise the estimated components of equation (5) and results from the
assessment of the welfare loss in Table 3. We calculate that the annual misuse of
antibiotics amounts to e6,777,659, representing 12% of the total spending in
outpatient antibiotics in 2002. Thus, we have identified the expected benefit
(e6,777,659) of reducing variations in antibiotic use due to heterogeneous atti-
tudes towards bacterial resistance. (Our argument is based on the premise that
the average rate of antibiotic consumption is optimal.)
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It is worth noting that the calculated welfare loss could be understated or
overstated16. First, our data are aggregated to the level of the area and cannot
capture within-area variation in the treatment of patients. This may cause us
to understate the overall welfare loss due to doctors’ attitudes towards the
risk of bacterial infections. However, the small size of our areas and their
internal homogeneity minimises this risk. Second, society is assumed to produce
antibiotics at a constant incremental cost. Overall welfare loss may exceed our
estimate if costs of production increase with the scale of production. Indeed,
this may be realistic if bacterial resistance reduces the effectiveness of antibiotic
treatment and consequently increases the costs of producing new, effective anti-
biotics. Finally, if the current average rate of antibiotic use is biased our meas-
ure of the welfare loss will also be biased. Clearly any additional gains from
reducing systematic bias in use will not be measured by our approach.
5. Conclusions
Understanding antibiotic treatment practices is necessary in order to reduce
antibiotic misuse and the cost of bacterial resistance. The major contribution
of this study is the investigation of sources of small area variations in the use
of antibiotics in the community and the assessment of the impact of physicians’
and patients’ heterogeneous attitudes. We propose a model in which antibiotic
use varies according to the demographic and socioeconomic characteristics of
the population, the incidence of infections, the local supply of health care and
the price of antibiotics. Estimations are carried out on 2002 quarterly data of
defined daily doses per 1,000 inhabitants per day (DID) available for 240 small
areas in Switzerland. Results suggest that demographic and socioeconomic
aspects only partially account for variations in outpatient antibiotic use across
small areas. Characteristics of the local supply, such as the density of doctors,
and consumption externalities across the areas are also relevant.
Because antibiotics are associated with bacterial resistance, differences in
physicians’ practice styles and patients’ attitudes are probably related to
attitudes towards the risks of bacterial resistance. Higher perceived levels of
Table 3. Assessment of the welfare loss from attitudes towards antibiotic use and implications of bac-
terial resistance
s2 DID* (1R2)CV2 1/« Total spending Welfare Loss %
CHF e CHF e
170.60 11.71 0.159 1.51 88,404,476 56,358,839 10,631,436 67,776,59 12.03
16 The main reasons for possible bias are discussed in detail in Parente and Phelps (1990).
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bacterial resistance induce physicians to switch to newer and more expensive
antibiotics in order to fight the infection effectively. The final effect may be
either an increase or a decrease in the per capita defined daily doses.
Looking at unexplained variations across the small areas, we assess the
impact of heterogeneity in antibiotic treatment practices. Although the litera-
ture suggests that there is a positive correlation between antibiotic use and res-
istance (Nilsson and Laurell, 2005; Garcia-Rey, 2004), the economic impact
has not yet been measured. Our assessment of the cost of variations in antibiotic
treatment styles may then provide a measure of the expected benefits of policy
interventions aimed at reducing the misuse of antibiotics.
The availability of information on the rate of bacterial resistance at the local
level would improve our estimation of the welfare loss. The lack of this
information prevents us from directly testing the effect of bacterial resistance
on the use of antibiotics. Data on bacterial resistance would also make it pos-
sible to distinguish between physicians’ responsiveness to variations in bacterial
resistance and other differences in practice style.
Despite these limitations, the analysis provides a first assessment of the
impact of determinants of small area variations in the use of antibiotics in the
community. The literature on small area variations argues that differences in
the utilisation of health care resources are largely driven by physician practice
style and supply variables rather than patient characteristics. Our findings add
to this body of study demonstrating the significant impact of local supply vari-
ables, but also by pointing to patients’ attributes as an important factor in small
area variations.
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